Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioferon PK/PD in Healthy Subjects
NCT02515695Phase 1Completed
- Sponsor
- Lausanne University Hospital
- Start
- May 2005
- Primary completion
- Jul 2005
- Modality
- Cytokines & Interferons
01
Overview
Phase 1, randomised, open-label trial of interferon beta-1a in multiple sclerosis (MS) (4 arms), sponsored by Lausanne University Hospital. Primary endpoints: Composite of interferon beta-1a PK parameters at 72 hours and Composite of interferon beta-1a PD markers at 168 hours. Started May 2005; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02515695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515695.